{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01606488",
            "orgStudyIdInfo": {
                "id": "20110506"
            },
            "secondaryIdInfos": [
                {
                    "id": "18F-AV-45-A14",
                    "type": "OTHER",
                    "domain": "Avid Radiopharmaceuticals"
                }
            ],
            "organization": {
                "fullName": "University of California, San Francisco",
                "class": "OTHER"
            },
            "briefTitle": "Effects of Brain Beta-Amyloid on Postoperative Cognition",
            "officialTitle": "Effects of Brain Beta Amyloid on Postoperative Cognition and 18F-AV-45-A14: Clinical Evaluation of Florbetapir F 18 (18F-AV-45)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "effects-of-brain-beta-amyloid-on-postoperative-cognition"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2012-05"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2023-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2012-05-23",
            "studyFirstSubmitQcDate": "2012-05-24",
            "studyFirstPostDateStruct": {
                "date": "2012-05-25",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2022-12-16",
            "lastUpdatePostDateStruct": {
                "date": "2022-12-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of California, San Francisco",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Alzheimer's Drug Discovery Foundation",
                    "class": "OTHER"
                },
                {
                    "name": "Avid Radiopharmaceuticals",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Postoperative cognitive decline (POCD) affects up to 50% of non-cardiac surgical patients greater than or equal to 65 years of age.\n\nThis study will test the hypothesis that preoperative presence of brain beta-amyloid plaques in non-demented subjects increases postoperative cognitive decline (POCD) in elderly subjects scheduled for hip or knee replacement.\n\nThe investigators hypothesize that preoperative beta-amyloid plaques will predict postoperative cognitive decline."
        },
        "conditionsModule": {
            "conditions": [
                "Postoperative Cognitive Dysfunction"
            ],
            "keywords": [
                "Postoperative Cognitive Dysfunction",
                "Postoperative Cognitive Decline",
                "POCD",
                "Alzheimer's disease",
                "Florbetapir F 18 (18F-AV-45)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Surgical Group",
                    "type": "OTHER",
                    "description": "Subjects scheduled to undergo total knee or total hip replacement at the SFVAMC.\n\nSubjects in this arm of the study will undergo the florbetapir PET scan once prior to their surgery.\n\nSubjects in this arm of the study will undergo serial neurocognitive assessment, heart rate variability measurement, and blood draws for genetic and inflammatory markers.",
                    "interventionNames": [
                        "Drug: Florbetapir F 18 (18F-AV-45)"
                    ]
                },
                {
                    "label": "Non-surgical group",
                    "type": "OTHER",
                    "description": "Subjects being seen in at the SFVAMC orthopedic clinic for knee or hip pain but are not anticipating surgical intervention.\n\nSubjects in this arm will not undergo the florbetapir PET scan.\n\nSubjects in this arm of the study will undergo serial neurocognitive assessment, heart rate variability measurement, and blood draws for genetic and inflammatory markers.",
                    "interventionNames": [
                        "Other: no intervention"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Florbetapir F 18 (18F-AV-45)",
                    "description": "Single IV bolus injection of 370 MBq (10mCi) florbetapir will be administered approximately 50 minutes prior to a 10 minute PET scan.",
                    "armGroupLabels": [
                        "Surgical Group"
                    ],
                    "otherNames": [
                        "Florbetapir",
                        "Amyvid 18F-AV-45"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "no intervention",
                    "armGroupLabels": [
                        "Non-surgical group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Cognitive Decline",
                    "description": "Measured using comprehensive neurocognitive test battery",
                    "timeFrame": "At the time of discharge (or at the latest on the 7th postoperative day)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Genetic Polymorphisms",
                    "description": "Measured by obtaining blood sample",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Vagus nerve tone assessment",
                    "description": "Measured using Heart Rate Variability (HRV)",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Inflammatory Markers",
                    "description": "Measured by obtaining blood samples",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Perioperative Complications",
                    "description": "Measured using patient medical records",
                    "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
                },
                {
                    "measure": "Delirium",
                    "description": "Measured using the Confusion Assessment Method rating scale (CAM) or the CAM-ICU if admitted to the intensive care unit",
                    "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
                },
                {
                    "measure": "Coma Assessment",
                    "description": "Measured using the Richmond Agitation Sedation Scale (RASS)",
                    "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
                },
                {
                    "measure": "Hospital Length of Stay",
                    "description": "Measured using patient medical records",
                    "timeFrame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
                },
                {
                    "measure": "Postoperative Complications",
                    "description": "Measured using patient medical records",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Change in Cognition",
                    "description": "Measured using comprehensive neurocognitive test battery",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Quality of Life",
                    "description": "Measured by assessing functional status using the Functional Activities Questionnaire and depression using the Geriatric Depression Scale",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Mortality",
                    "description": "Measured using patient medical records",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Pain intensity",
                    "description": "Measured using the Numerical Rating Scale",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Pain unpleasantness",
                    "description": "Measured using the Numerical Rating Scale",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                },
                {
                    "measure": "Post-traumatic Stress Disorder symptomatology",
                    "description": "Measured using the PTSD Checklist",
                    "timeFrame": "Participants will be followed from preoperative baseline to 1 year postoperative"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Scheduled for total knee arthroplasty or total hip arthroplasty under general anesthesia (primary arthroplasties and revisions)\n* English speaking\n* Anticipated stay in the hospital\n* Not anticipated to stay intubated postoperatively\n* Patients who live with or have regular visits from an individual (\"study partner\") willing to provide information about the patient's cognitive status\n* Willing and able to undergo all testing procedures including neuroimaging and agree to longitudinal follow up\n* Adequate visual and auditory acuity to allow neuropsychological testing\n* Subjects with Clinical Dementia Rating Scale (CDR) of 0-0.5\n* Patients who are not demented\n* Subjects sho signed an IRB approved informed consent prior to any study procedures\n\nExclusion Criteria:\n\n* Clinically significant hepatic, renal, pulmonary, metabolic, or endocrine disturbances as indicated by history, which in the opinion of the investigator might pose a potential safety risk to the subject\n* Current clinically significant cardiovascular disease.\n* History of drug or alcohol abuse within the last year, or prior prolonged history of abuse\n* Clinically significant infections disease, including Acquired Immune Deficiency Syndrome (AIDS) or Human Immunodeficiency Virus (HIV) infection or previous positive test for hepatitis\n* History of relevant severe drug allergy or hypersensitivity\n* Received an investigational medication under an FDA IND protocol within the last 30 days.\n* Current clinically significant unstable medical comorbidities, as indicated by history or physical exam, that pose a potential safety risk to the subject\n* Received a radiopharmaceutical for imaging or therapy within the past 24 hours prior to the imaging session for this study\n* Severe psychiatric disorders including schizophrenia, bipolar disorders, and major depression as described in DSM-IV within the past year (medical record, GDS score, interview with the patient and study partner)\n* Obvious causes for their cognitive impairment (e.g. onset coincides with recent head trauma or stroke)\n* Dementia of any cause\n* CDR score \\> 0.5\n* Expressed the preference to undergo the procedure under regional anesthesia in form of spinal or epidural anesthesia\n* Patients who, in the opinion of the investigator, are otherwise unsuitable for a study of this type",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "65 Years",
            "stdAges": [
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Marek Brzezinski, MD, PhD",
                    "role": "CONTACT",
                    "phone": "877-487-2838",
                    "email": "brzezinm@anesthesia.ucsf.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Marek Brzezinski, MD, PhD",
                    "affiliation": "University of California, San Francisco",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "San Francisco VA Medical Center",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94121",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marek Brzezinski, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Kim Hubert, MD, PhD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Carina Mari Aparici, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Michael Weiner, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "John Kornak, PhD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Joel H Kramer, PsyD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Mervyn Maze, MB, ChB",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000079690",
                    "term": "Postoperative Cognitive Complications"
                },
                {
                    "id": "D000060825",
                    "term": "Cognitive Dysfunction"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003072",
                    "term": "Cognition Disorders"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000011183",
                    "term": "Postoperative Complications"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3885",
                    "name": "Alzheimer Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M29705",
                    "name": "Cognitive Dysfunction",
                    "asFound": "Cognitive Dysfunction",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4021",
                    "name": "Amyloidosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M2076",
                    "name": "Postoperative Cognitive Complications",
                    "asFound": "Postoperative Cognitive Dysfunction",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6301",
                    "name": "Cognition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14065",
                    "name": "Postoperative Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "T2192",
                    "name": "Familial Alzheimer Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}